Developing tools to study the immune response to influenza
Tetramer Research & Development Contract (Influenza)
This study is working on making special tools that help scientists learn how our immune system fights off infections like the flu, so they can create better vaccines and treatments for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10678192 on NIH RePORTER |
What this research studies
This research focuses on enhancing the production and distribution of specialized reagents that help scientists study how the immune system responds to infections like influenza. By improving these reagents, researchers can better understand how T cells recognize and respond to viral infections, which is crucial for developing effective vaccines and treatments. The project aims to streamline the production process, making these tools more accessible for various studies in immunology and infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals interested in the immune response to infectious diseases, particularly those at risk for influenza.
Not a fit: Patients who are not affected by infectious diseases or those who do not have a significant immune response issue may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines and therapies for influenza and other infectious diseases.
How similar studies have performed: Previous research has shown success in using similar reagents to enhance understanding of immune responses, indicating a promising approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Altman, John — Emory University
- Study coordinator: Altman, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.